<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Generic Pharma 2.0</title>
	<atom:link href="http://genericpharma20.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://genericpharma20.com</link>
	<description>CONSULTING, COMMUNICATIONS &#38; DATA TO HELP THE GENERIC INDUSTRY GROW</description>
	<lastBuildDate>Fri, 18 May 2012 15:05:32 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Opportunities</title>
		<link>http://genericpharma20.com/opportunities/</link>
		<comments>http://genericpharma20.com/opportunities/#comments</comments>
		<pubDate>Tue, 15 May 2012 20:16:53 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Opportunities]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=455</guid>
		<description><![CDATA[Current Opportunities These are the current opportunities being worked on by the GP20 team. &#160; &#160; &#160; &#160; &#160; &#160; Free $0/month Basic $25/month Professional $75/month Business $50/month Users 1 5 50 10 Storage Space 10MB 30MB 100MB 50MB File Transfer 10GB/month 30GB/month 100GB/month 50GB/month MySQL 10 database 20 database 100 database 50 database Reports &#160; &#160; &#160; &#160; Secure&#8230;]]></description>
			<content:encoded><![CDATA[<p><center></p>
<h2>Current Opportunities</h2>
<h4>These are the current opportunities being worked on by the GP20 team.</h4>
<p></center></p>
<table class="pricing_table" cellspacing="0">
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td class="top_featured_orange">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr class="price_head">
<td class="price_headtop">&nbsp;</td>
<td>
<h2>Free</h2>
<h3>$0/month</h3>
</td>
<td>
<h2>Basic</h2>
<h3>$25/month</h3>
</td>
<td class="featured_orange">
<h2>Professional</h2>
<h3>$75/month</h3>
</td>
<td>
<h2>Business</h2>
<h3>$50/month</h3>
</td>
</tr>
<tr class="price_body">
<td class="title">Users</td>
<td>1</td>
<td>5</td>
<td class="featured_orange">50</td>
<td>10</td>
</tr>
<tr class="price_body">
<td class="title">Storage Space</td>
<td>10MB</td>
<td>30MB</td>
<td class="featured_orange">100MB</td>
<td>50MB</td>
</tr>
<tr class="price_body">
<td class="title">File Transfer</td>
<td>10GB/month</td>
<td>30GB/month</td>
<td class="featured_orange">100GB/month</td>
<td>50GB/month</td>
</tr>
<tr class="price_body">
<td class="title">MySQL</td>
<td>10 database</td>
<td>20 database</td>
<td class="featured_orange">100 database</td>
<td>50 database</td>
</tr>
<tr class="price_body">
<td class="title">Reports</td>
<td><span class="price_icons no">&nbsp;</span></td>
<td><span class="price_icons plus">&nbsp;</span></td>
<td class="featured_orange"><span class="price_icons yes">&nbsp;</span></td>
<td><span class="price_icons info">&nbsp;</span></td>
</tr>
<tr class="price_body">
<td class="title">Secure SSL</td>
<td><span class="price_icons no">&nbsp;</span></td>
<td><span class="price_icons yes">&nbsp;</span></td>
<td class="featured_orange"><span class="price_icons yes">&nbsp;</span></td>
<td ><span class="price_icons yes">&nbsp;</span></td>
</tr>
<tr class="price_body">
<td class="title">Add-ons</td>
<td><span class="price_icons no">&nbsp;</span></td>
<td><span class="price_icons yes">&nbsp;</span></td>
<td class="featured_orange"><span class="price_icons yes">&nbsp;</span></td>
<td><span class="price_icons yes">&nbsp;</span></td>
</tr>
<tr class="price_body">
<td class="title">Free Support</td>
<td><span class="price_icons yes">&nbsp;</span></td>
<td><span class="price_icons yes">&nbsp;</span></td>
<td class="featured_orange"><span class="price_icons yes">&nbsp;</span></td>
<td><span class="price_icons yes">&nbsp;</span></td>
</tr>
<tr class="sign_up">
<td >&nbsp;</td>
<td><span class="button_span"><a href="#" target=""><span>Buy now!</span></a></span></td>
<td><span class="button_span"><a href="#" target=""><span>Buy now!</span></a></span></td>
<td class="featured_orange"><span class="button_span"><a href="#" target=""><span>Buy now!</span></a></span></td>
<td><span class="button_span"><a href="#" target=""><span>Buy now!</span></a></span></td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td class="bottom_featured_orange">&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/opportunities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Free Webinar Series- Regulatory Issues in the U.S &amp; Europe</title>
		<link>http://genericpharma20.com/374/</link>
		<comments>http://genericpharma20.com/374/#comments</comments>
		<pubDate>Wed, 04 Apr 2012 18:24:53 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Future Pharma]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=374</guid>
		<description><![CDATA[SPEAKERS Jeff Guise- Partner Lorelei Weston- Associate ~There is NO cost to attend~  Also brought to you by: ]]></description>
			<content:encoded><![CDATA[<p><img class="size-full wp-image-375 aligncenter" title="WSGR" src="http://genericpharma20.com/wp-content/uploads/2012/04/WSGR.jpg" alt="" width="564" height="792" /></p>
<h1 style="text-align: center;"><span style="color: #888888;">SPEAKERS</span></h1>
<h3 style="text-align: center;"><span style="color: #3366ff;"><a href="http://www.wsgr.com/WSGR/DBIndex.aspx?SectionName=attorneys/BIOS/7514.htm"><span style="color: #3366ff;">Jeff Guise- Partner</span></a></span></h3>
<h3 style="text-align: center;"><span style="color: #3366ff;"><a href="http://www.wsgr.com/WSGR/DBIndex.aspx?SectionName=attorneys/BIOS/7602.htm"><span style="color: #3366ff;">Lorelei Weston- Associate</span></a></span></h3>
<p style="text-align: center;"><a href="http://www.wsgr.com/WSGR/Display.aspx?SectionName=news/emailer/Event351"><img class="wp-image-376 aligncenter" title="register_button" src="http://genericpharma20.com/wp-content/uploads/2012/04/register_button-300x266.png" alt="" width="180" height="160" /></a></p>
<p style="text-align: center;"><strong><span style="color: #000000;">~There is NO cost to attend~ </span></strong></p>
<p style="text-align: center;"><span style="color: #000000;">Also brought to you by: </span></p>
<p><a href="http://www.biosimilarlicensing.com"><img class="size-medium wp-image-377 aligncenter" title="biosimilar_licensing" src="http://genericpharma20.com/wp-content/uploads/2012/04/biosimilar_licensing-300x63.png" alt="" width="300" height="63" /></a></p>
<p><a href="http://www.newpharmamag.com"><img class="size-medium wp-image-410 aligncenter" title="NP_Black" src="http://genericpharma20.com/wp-content/uploads/2012/04/NP_Black-300x131.jpg" alt="" width="300" height="131" /></a></p>
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/374/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>B2B Social Selling</title>
		<link>http://genericpharma20.com/b2b-social-selling/</link>
		<comments>http://genericpharma20.com/b2b-social-selling/#comments</comments>
		<pubDate>Thu, 29 Mar 2012 13:30:27 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Homepage 'Article']]></category>
		<category><![CDATA[GP20]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=350</guid>
		<description><![CDATA[Talk to us about evolving your marketing strategy to gain new clients and partners!]]></description>
			<content:encoded><![CDATA[<h2><span style="color: #000080;">Talk to us about evolving your marketing strategy to gain new clients and partners!</span></h2>
<p><img class="alignnone" title="B2B Social Selling" src="http://www.insideview.com/images/B2B_SocialMedia_Insideview.jpg" alt="" width="940" height="2045" /></p>
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/b2b-social-selling/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What would you attempt&#8230;</title>
		<link>http://genericpharma20.com/what-would-you-attempt/</link>
		<comments>http://genericpharma20.com/what-would-you-attempt/#comments</comments>
		<pubDate>Wed, 28 Mar 2012 15:47:43 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Future Pharma?]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=330</guid>
		<description><![CDATA[What would you attempt to do if you knew you could not fail? asks Regina Dugan, then director of DARPA, the Defense Advanced Research Projects Agency. In this breathtaking talk she describes some of the extraordinary projects &#8212; a robotic hummingbird, a prosthetic arm controlled by thought, and, well, the internet &#8212; that her agency has created by not worrying&#8230;]]></description>
			<content:encoded><![CDATA[<p><strong><span style="font-family: arial, helvetica, sans-serif; font-size: 12px; line-height: normal; text-align: left; background-color: #ffffff;">What would you attempt to do if you knew you could not fail?</span></strong></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12px; line-height: normal; text-align: left; background-color: #ffffff;"> asks Regina Dugan, then director of DARPA, the Defense Advanced Research Projects Agency. In this breathtaking talk she describes some of the extraordinary projects &#8212; a robotic hummingbird, a prosthetic arm controlled by thought, and, well, the internet &#8212; that her agency has created by not worrying that they might fail.</span></p>
<p><a href="http://www.ted.com/talks/regina_dugan_from_mach_20_glider_to_humming_bird_drone.html?utm_source=newsletter_weekly_2012-03-28&amp;utm_campaign=newsletter_weekly&amp;utm_medium=email">Regina Dugan: From mach-20 glider to humming bird drone | Video on TED.com</a>.</p>
<p><img class="alignnone" title="Ted Talks" src="http://images.ted.com/images/ted/2335b2e44dc456891306c79c91e11ecc627ea85b_132x99.jpg" alt="" width="132" height="99" /></p>
<p>What would you try?</p>
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/what-would-you-attempt/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Pharma Magazine</title>
		<link>http://genericpharma20.com/new-pharma-mag/</link>
		<comments>http://genericpharma20.com/new-pharma-mag/#comments</comments>
		<pubDate>Wed, 28 Mar 2012 15:30:36 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Interesting]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=319</guid>
		<description><![CDATA[New Pharma is a pharmaceutical magazine like no other, with exclusive content specializing in Generics, Otc, Biosimilar and Animal Health. Key topics include strategy, marketing, technology, business culture, law and emerging markets. New Pharma Magazine is not a science journal and is focused on engaging readers on a corporate level, in terms of strategy and direction of the industry over&#8230;]]></description>
			<content:encoded><![CDATA[<p>New Pharma is a pharmaceutical magazine like no other, with exclusive content specializing in Generics, Otc, Biosimilar and Animal Health. Key topics include strategy, marketing, technology, business culture, law and emerging markets. New Pharma Magazine is not a science journal and is focused on engaging readers on a corporate level, in terms of strategy and direction of the industry over all.</p>
<p><em> &#8221;New Pharma is an exciting new publication that reflects the need for strategic thinking in a changing industry&#8221; &#8211; Ed Borkowski, former CFO Mylan</em></p>
<p>New Pharma Magazine is available in print and digital. You can subscribe <span style="color: #800000;"><a href="http://www.newpharmamag.com/"><span style="color: #800000;">FOR FREE</span></a></span> on the newly launched website and gain access to premium content, industry events, news and partners.</p>
<p style="text-align: center;"><span style="color: #800000;"><a href="http://www.newpharmamag.com/"><span style="color: #800000;">DOWNLOAD YOUR FREE DIGITAL COPY TODAY</span></a></span></p>
<p style="text-align: center;"><a href="http://www.newpharmamag.com/"><img class="aligncenter size-full wp-image-424" title="NewPharmaCover1" src="http://genericpharma20.com/wp-content/uploads/2012/03/NewPharmaCover11.jpg" alt="" width="220" height="301" /></a></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/new-pharma-mag/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Innovative Companies in Healthcare 2012</title>
		<link>http://genericpharma20.com/the-worlds-50-most-innovative-companies-in-healthcare-2012-fast-company/</link>
		<comments>http://genericpharma20.com/the-worlds-50-most-innovative-companies-in-healthcare-2012-fast-company/#comments</comments>
		<pubDate>Wed, 28 Mar 2012 14:21:34 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Companies]]></category>
		<category><![CDATA[Company]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=292</guid>
		<description><![CDATA[The World’s 50 Most Innovative Companies in Healthcare 2012 &#124; Fast Company. When will there be a generic company on this list? What kind of innovations could there be in the industry to make such an impact on the world?]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.fastcompany.com/most-innovative-companies/2012/industry/healthcare#nationalmarrowdonorprogram">The World’s 50 Most Innovative Companies in Healthcare 2012 | Fast Company</a>.</p>
<p>When will there be a generic company on this list?<br />
What kind of innovations could there be in the industry to make such an impact on the world?</p>
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/the-worlds-50-most-innovative-companies-in-healthcare-2012-fast-company/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Nokia vibrating tattoo!</title>
		<link>http://genericpharma20.com/the-nokia-vibrating-tattoo/</link>
		<comments>http://genericpharma20.com/the-nokia-vibrating-tattoo/#comments</comments>
		<pubDate>Wed, 28 Mar 2012 13:46:50 +0000</pubDate>
		<dc:creator>GP20</dc:creator>
				<category><![CDATA[Future Pharma]]></category>
		<category><![CDATA[Future Pharma?]]></category>

		<guid isPermaLink="false">http://genericpharma20.com/?p=264</guid>
		<description><![CDATA[The Nokia vibrating tattoo! &#124; Nokia Connects. Could there be a time when long acting drugs could be tattooed?]]></description>
			<content:encoded><![CDATA[<p><a href="http://nokiaconnects.com/2012/03/20/the-nokia-vibrating-tattoo/">The Nokia vibrating tattoo! | Nokia Connects</a>.</p>
<p>Could there be a time when long acting drugs could be tattooed?</p>
<p style="text-align: center;">
]]></content:encoded>
			<wfw:commentRss>http://genericpharma20.com/the-nokia-vibrating-tattoo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

